Vimkunya is a vaccine used to protect adults and adolescents from 12 years of age against chikungunya. Chikungunya is a disease caused by chikungunya virus, which is transmitted to humans by infected mosquitoes. Vimkunya contains proteins from a chikungunya virus strain called Senegal strain 37997 (capsid protein and envelope proteins E1 and E2). These proteins are assembled into virus-like particles that are not infectious. The vaccine cannot cause chikungunya in people who receive the vaccine.
Therapeutic Indication
N/A
Therapeutic Area (MeSH)
ATC Code
N/A
ATC Item
N/A
Pharmacotherapeutic Group
N/A
Active Substance (Summary)
INN / Common Names
| Substance | CAS | Monograph |
|---|---|---|
| Chikungunya virus (CHIKV) virus-like particle (VLP) proteins (capsid protein (C) and envelope proteins E1 and E2) derived from CHIKV Senegal strain 37997 produced in human embryonic kidney cells by recombinant DNA technology, adsorbed on aluminium hydroxide, hydrated | N/A | chikungunya virus (chikv) virus-like particle (vlp) proteins (capsid protein (c) and envelope proteins e 1 and e 2) derived from chikv senegal strain 37997 produced in human embryonic kidney cells by recombinant dna technology, adsorbed on aluminium hydroxide, hydrated |
EMA Name
Vimkunya
Medicine Name
Vimkunya
Aliases
N/ANo risk management plan link.
